Prospective development and validation of a model to predict heart failure hospitalisation

Heart

Volumn 100, Issue 12, 2014, Pages 923-929

  Cubbon, R M ^a   Woolston, A ^a   Adams, B ^a   Gale, C P ^a   Gilthorpe, M S ^a   Baxter, P D ^a   Kearney, L C ^a   Mercer, B ^a   Rajwani, A ^a   Batin, P D ^b   Kahn, M ^a   Sapsford, J ^c   Witte, K K ^a   Kearney, M T ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE;

ACUTE HEART FAILURE SYNDROME; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HOSPITALIZATION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LOW RISK PATIENT; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; THORAX RADIOGRAPHY; VALIDATION PROCESS;

AGED; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84901589619     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305294     Document Type: Article

References (40)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146.
2. Chen J, Normand S, Wang Y, et al. National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries, 1998-2008. JAMA 2011;306:1669-78.
3. Ross JS, Chen J, Lin Z, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010;3:97-103.
4. Solomon SD, Dobson J, Pocock S, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007;116:1482-7. (Pubitemid 47480639)
5. Lee DS, Austin PC, Stukel TA, et al. "Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med 2009;122:162.
6. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007;154:260-6. (Pubitemid 47079017)
7. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-7. (Pubitemid 37443288)
8. Mozaffarian D, Anker SD, Anand I, et al. Prediction of mode of death in heart failure: the seattle heart failure model. Circulation 2007;116:392-8. (Pubitemid 47196544)
9. Ross JS, Mulvey GK, Stauffer B, et al. Statistical models and patient predictors of readmission for heart failure: a systematic review. Arch Intern Med 2008;168:1371-86. (Pubitemid 352008418)
10. Keenan PS, Normand SL, Lin Z, et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 2008;1:29-37.
11. Philbin E, DiSalvo T. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol 1999;33:1560-6.
12. Yamokoski L, Hasselblad V, Moser D, et al. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail 2007;13:8-13. (Pubitemid 46330838)
13. Kearney MT, Fox KAA, Lee AJ, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002;40:1801-8. (Pubitemid 35341959)
14. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Int Med 1999;130:461-70. (Pubitemid 29135798)
15. British Society of Echocardiography. http://www.bsecho.org (accessed 20 Mar 2010).
16. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiog 2005;18:1440-63. (Pubitemid 41821197)
17. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th edn. Boston, Mass: Little, Brown & Co., 1994.
18. Cubbon RM, Gale CP, Kearney LC, et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail 2011;4:396-403.
19. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart dailure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998;98:1510-16. (Pubitemid 28481667)
20. Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005;112:3958-68. (Pubitemid 43739494)
21. United Kingdom National Statistics Publications Hub. http://www. statistics.gov.uk/STATBASE/ssdataset.asp?vlnk=9552E (accessed 18 Feb 2010).
22. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol 2009;53:557-73.
23. Adams J, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-16. (Pubitemid 40348525)
24. Dunlay SM, Redfield MM, Weston SA, et al. Hospitalizations after heart failure diagnosis: a community perspective. J Am Coll Cardiol 2009;54:1695-702.
25. Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226-9. (Pubitemid 36135215)
26. Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007;116:1549-54. (Pubitemid 47511418)
27. Beohar N, Erdogan AK, Lee DC, et al. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol 2008;52:13-16. (Pubitemid 351852938)
28. Milo O, Cotter G, Kaluski E, et al. Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol 2003;92:222-6. (Pubitemid 36835978)
29. Peacock WF IV, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117-26. (Pubitemid 351679598)
30. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-8. (Pubitemid 23007515)
31. Green CP, Porter CB, Bresnahan DR, et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245-55. (Pubitemid 30206900)
32. Russell SD, Saval MA, Robbins JL, et al. New York Heart Association functional class predicts exercise parameters in the current era. Am Heart J 2009;158:S24-30.
33. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-33. (Pubitemid 43739439)
34. Kubo SH, Schulman S, Starling RC, et al. Development and validation of a patient questionnaire to determine New York heart association classification. J Card Fail 2004;10:228-35. (Pubitemid 38869464)
35. Francis G, Sigel R, Goldsmith S, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Int Med 1985;103:1-6. (Pubitemid 15068490)
36. Silver MA, Horton DP, Ghali JK, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 2002;39:798-803. (Pubitemid 34185326)
37. MacDonald MR, Jhund PS, Petrie MC, et al. Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circ Heart Fail 2008;1:234-41.
38. MacDonald MR, Petrie MC, Varyani F, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure. Eur Heart J 2008;29:1377-85.
39. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-41. (Pubitemid 38229537)
40. Radauceanu A, Ducki C, Virion JM, et al. Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. J Card Fail 2008;14:467-74. (Pubitemid 352040864)